Study Title: Phase II Study Evaluating NALIRIFOX versus Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients with Locally Advanced and Metastatic Pancreatic Adenocarcinoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Dincman, Toros, at dincmant@musc.edu.Study Coordinator, Concepcion, Holly, at concepch@musc.edu.Trial opened at the following institutions: Medical University of South Carolina